Sodium Benzoate Add-on Treatment for Refractory Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial

被引：0
|
作者：
Lin, Chieh-Hsin [1 ,2 ]
Chang, Yue-Cune [3 ]
Lane, Hsien-Yuan [1 ,4 ]
机构：
[1] China Med Univ, Inst Clin Med Sci, Taichung, Taiwan
[2] Chang Gung Univ, Coll Med, Dept Psychiat, Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan
[3] Tamkang Univ, Dept Math, Taipei, Taiwan
[4] China Med Univ Hosp, Dept Psychiat, 2 Yuh Der Rd, Taichung 404, Taiwan
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2016年 / 19卷
关键词：
N-methyl-D-aspartate; refractory schizophrenia; D-amino acids oxidase (DAAO) inhibitor; sodium benzoate; clinical trial;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PM405
引用
收藏
页码：196 / 196
页数：1
相关论文
共 50 条
  • [1] Add-on Treatment of Benzoate for Schizophrenia A Randomized, Double-blind, Placebo-Controlled Trial of D-Amino Acid Oxidase Inhibitor
    Lane, Hsien-Yuan
    Lin, Ching-Hua
    Green, Michael F.
    Hellemann, Gerhard
    Huang, Chih-Chia
    Chen, Po-Wei
    Tun, Rene
    Chang, Yue-Cung
    Tsai, Guochuan E.
    [J]. JAMA PSYCHIATRY, 2013, 70 (12) : 1267 - 1275
  • [2] Ramosetron as an add-on therapy for refractory fibromyalgia: a randomized, double-blind, placebo-controlled trial
    Park, Dong-Jin
    Jeong, Hyemin
    Choi, Sung-Eun
    Kang, Ji-Hyoun
    Lee, Jung-Kil
    Lee, Shin-Seok
    [J]. RHEUMATOLOGY, 2024, 63 (09) : 2372 - 2378
  • [3] Topiramate add-on in treatment-resistant schizophrenia:: A randomized, double-blind, placebo-controlled, crossover trial
    Tiihonen, J
    Halonen, P
    Wahlbeck, K
    Repo-Tiihonen, E
    Hyvärinen, S
    Eronen, M
    Putkonen, H
    Takala, P
    Mehtonen, IP
    Puck, M
    Oksanen, J
    Koskelainen, P
    Joffe, G
    Aer, J
    Hallikainen, T
    Ryynänen, IP
    Tupala, E
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (08) : 1012 - 1015
  • [4] Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial
    Afshar, H.
    Roohafza, H.
    Mousavi, G.
    Golchin, S.
    Toghianifar, N.
    Sadeghi, M.
    Talaei, M.
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2009, 23 (02) : 157 - 162
  • [5] Antipsychotic Effects of Celecoxib Add-On Haloperidol in Schizophrenia: A Randomized Double-Blind Placebo-Controlled Clinical Trial
    Zarghami, Mehran
    Dodangi, Nasrin
    Azari, Paria
    Khalilian, Alireza
    [J]. IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES, 2024, 18 (01)
  • [6] ALLOPURINOL AS ADD-ON THERAPY IN REFRACTORY EPILEPSY - A DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED STUDY
    ZAGNONI, PG
    BIANCHI, A
    ZOLO, P
    CANGER, R
    CORNAGGIA, C
    DALESSANDRO, P
    DEMARCO, P
    PISANI, F
    GIANELLI, M
    VERZE, L
    VIANI, F
    ZACCARA, G
    [J]. EPILEPSIA, 1994, 35 (01) : 107 - 112
  • [7] Effects of add-on mirtazapine on neurocognition in schizophrenia: a double-blind, randomized, placebo-controlled study
    Stenberg, Jan-Henry
    Terevnikov, Viatcheslav
    Joffe, Marina
    Tiihonen, Jari
    Tchoukhine, Evgueni
    Burkin, Mark
    Joffe, Grigori
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 (04): : 433 - 441
  • [8] Improvement of Negative and Positive Symptoms in Treatment-Refractory Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Trial With Memantine as Add-On Therapy to Clozapine
    de Lucena, David
    Fernandes, Brisa Simoes
    Berk, Michael
    Dodd, Seetal
    Medeiros, Dalton W.
    Pedrini, Mariana
    Kunz, Mauricio
    Gomes, Fabiano Alves
    Giglio, Larriany F.
    Lobato, Maria Ines
    Belmonte-de-Abreu, Paulo Silva
    Gama, Clarissa Severino
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (10) : 1416 - 1423
  • [9] DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FLUNARIZINE AS ADD-ON THERAPY IN REFRACTORY CHILDHOOD EPILEPSY
    BATTAGLIA, A
    FERRARI, AR
    GUERRINI, R
    [J]. BRAIN & DEVELOPMENT, 1991, 13 (04): : 217 - 222
  • [10] Curcumin as Add-On to Antipsychotic Treatment in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study
    Miodownik, Chanoch
    Lerner, Vladimir
    Kudkaeva, Natalie
    Lerner, Paul P.
    Pashinian, Artashez
    Bersudsky, Yuly
    Eliyahu, Ronen
    Kreinin, Anatoly
    Bergman, Joseph
    [J]. CLINICAL NEUROPHARMACOLOGY, 2019, 42 (04) : 117 - 122
12345